”Sweden is number eight on the list of European countries that receive the most money” says Johan Lindberg at Vinnova, who helps Swedish companies to apply for EU grants.
So far, Sweden has received SEK 10 billion through the EU Innovation Fund Horizon 2020, of which 25 million was allocated to Lipum for the development of drugs for children and adults with chronic, inflammatory diseases.
”This type of financial support gives us an important push forward,” says Einar Pontén. A form of validation of promising companies in an early phase, thereby becoming more attractive to private venture capital. ”